Pharmacotherapy

Journal

Publication Venue For

  • Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.  42:529-539. 2022
  • Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.  38:588-596. 2018
  • Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.  37:1366-1373. 2017
  • Effect of Prescription Drug Coupons on Statin Utilization and Expenditures: A Retrospective Cohort Study.  37:12-24. 2017
  • Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.  36:781-796. 2016
  • Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage among Warfarin Users.  36:263-272. 2016
  • Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications.  34:545-554. 2014
  • Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension.  33:798-811. 2013
  • Reversal of oral anticoagulation.  33:1199-1213. 2013
  • Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumor.  32:274-284. 2012
  • Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infection.  32:142-147. 2012
  • Hansen's disease (Leprosy): Current and future pharmacotherapy and treatment of disease-related immunologic reactions.  32:27-37. 2012
  • Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.  31:510-523. 2011
  • Warfarin pharmacogenetics.  28:1084-1097. 2008
  • Pharmacokinetics of an indinavir-ritonavir-fosamprenavir regimen in patients with human immunodeficiency virus.  28:74-81. 2008
  • Institutional experience with voriconazole compared with liposomal amphotericin b as empiric therapy for febrile neutropenia.  27:970-979. 2007
  • Combating influenza with antiviral therapy in the pediatric population.  26:95-103. 2006
  • Exacerbation of panic disorder with rifampin therapy in a patient receiving citalopram.  25:435-437. 2005
  • Tactics for vascular protection after acute ischemic stroke.  25:387-395. 2005
  • Indinavir concentrations and antiviral effect.  19:708-712. 1999
  • A pilot study of estrogen's effects on bronchial myocyte adhesion molecule expression.  19:1426-1431. 1999
  • Cyclosporine-induced Ī²-adrenergic receptor down-regulation in bovine pulmonary artery smooth muscle cells: A pilot study.  18:341-344. 1998
  • Tramadol-warfarin interaction.  18:871-873. 1998
  • Pharmacokinetics and safety of concentration-controlled oral zidovudine therapy.  17:424-430. 1997
  • Opiate Receptors: Opioid Agonistā€Antagonist Effects.  11:164-167. 1991
  • Acyclovir: Mechanism of Action, Pharmacokinetics, Safety and Clinical Applications.  3:275-283. 1983
  • International Standard Serial Number (issn)

  • 0277-0008
  • Electronic International Standard Serial Number (eissn)

  • 1875-9114